Cargando…

Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management

Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hemophilia B (sHB) treated with FIX‐Fc fusion protein (rFIXFc) who und...

Descripción completa

Detalles Bibliográficos
Autores principales: Benitez Hidalgo, Olga, Martinez Garcia, M. Fernanda, Bescos Cabestre, Agustin, Juarez Gimenez, Juan Carlos, Gironella Mesa, Mercedes, Bosch Albareda, Francesc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127245/
https://www.ncbi.nlm.nih.gov/pubmed/35620255
http://dx.doi.org/10.1002/ccr3.5848
_version_ 1784712308491026432
author Benitez Hidalgo, Olga
Martinez Garcia, M. Fernanda
Bescos Cabestre, Agustin
Juarez Gimenez, Juan Carlos
Gironella Mesa, Mercedes
Bosch Albareda, Francesc
author_facet Benitez Hidalgo, Olga
Martinez Garcia, M. Fernanda
Bescos Cabestre, Agustin
Juarez Gimenez, Juan Carlos
Gironella Mesa, Mercedes
Bosch Albareda, Francesc
author_sort Benitez Hidalgo, Olga
collection PubMed
description Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hemophilia B (sHB) treated with FIX‐Fc fusion protein (rFIXFc) who underwent neurosurgery.
format Online
Article
Text
id pubmed-9127245
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91272452022-05-25 Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management Benitez Hidalgo, Olga Martinez Garcia, M. Fernanda Bescos Cabestre, Agustin Juarez Gimenez, Juan Carlos Gironella Mesa, Mercedes Bosch Albareda, Francesc Clin Case Rep Case Reports Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hemophilia B (sHB) treated with FIX‐Fc fusion protein (rFIXFc) who underwent neurosurgery. John Wiley and Sons Inc. 2022-05-23 /pmc/articles/PMC9127245/ /pubmed/35620255 http://dx.doi.org/10.1002/ccr3.5848 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Benitez Hidalgo, Olga
Martinez Garcia, M. Fernanda
Bescos Cabestre, Agustin
Juarez Gimenez, Juan Carlos
Gironella Mesa, Mercedes
Bosch Albareda, Francesc
Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
title Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
title_full Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
title_fullStr Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
title_full_unstemmed Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
title_short Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
title_sort neurosurgery in a patient with severe hemophilia b: an experience using eftrenonacog alfa as perioperative management
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127245/
https://www.ncbi.nlm.nih.gov/pubmed/35620255
http://dx.doi.org/10.1002/ccr3.5848
work_keys_str_mv AT benitezhidalgoolga neurosurgeryinapatientwithseverehemophiliabanexperienceusingeftrenonacogalfaasperioperativemanagement
AT martinezgarciamfernanda neurosurgeryinapatientwithseverehemophiliabanexperienceusingeftrenonacogalfaasperioperativemanagement
AT bescoscabestreagustin neurosurgeryinapatientwithseverehemophiliabanexperienceusingeftrenonacogalfaasperioperativemanagement
AT juarezgimenezjuancarlos neurosurgeryinapatientwithseverehemophiliabanexperienceusingeftrenonacogalfaasperioperativemanagement
AT gironellamesamercedes neurosurgeryinapatientwithseverehemophiliabanexperienceusingeftrenonacogalfaasperioperativemanagement
AT boschalbaredafrancesc neurosurgeryinapatientwithseverehemophiliabanexperienceusingeftrenonacogalfaasperioperativemanagement